Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Sexually Transmitted Diseases (STD) Testing Industry?

Significant growth has been noticed in the sexually transmitted diseases (std) testing market in the recent past. The market is predicted to increase from $8.08 billion in 2024 to $8.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.6%. Urbanization and a rise in population density, combined with an older population maintaining active sexual habits, have led to this expansion in the historic period. Other factors contributing to this growth include government-driven STD screening initiatives, the incorporation of STD testing in regular health check-ups, and augmented funding for public health schemes.

In the coming years, the sexually transmitted diseases (std) testing market is set to experience robust growth. It is anticipated to reach $12.08 billion by 2029, with a compound annual growth rate (CAGR) of 8.3%. This growth forecast is primarily driven by the increasing universal prevalence of STDs, heightened awareness about sexual health, the widespread occurrence of symptom-less infections, the growing number of sexually active teenagers and young adults, and escalating instances of risky sexual behavior. Significant trends projected for this period include the introduction of rapid and point-of-care testing, the emergence of home-use STD testing kits, advancements in molecular diagnosis methodologies, the use of automation and AI technology in diagnostic labs, and enhanced sensitivity and specificity of new test kits.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24695&type=smp

#Which Factors Are Currently Driving The Growth Of The Sexually Transmitted Diseases (STD) Testing Market?

The increase in HIV instances is expected to fuel the expansion of the market for sexually transmitted diseases (STD) testing in the near future. HIV is a virus that undermines the immune system by attacking and eliminating essential white blood cells, leaving the body more susceptible to infections and diseases. The uptick in HIV is attributed to a decrease in awareness and prevention measures, leading to more individuals participating in hazardous behaviors like unprotected sex and less individuals undergoing screening, particularly amongst young people. This increase in HIV instances bolsters the need for sexually transmitted disease (STD) testing by increasing public and healthcare awareness, leading more people to pursue comprehensive testing to detect infections at an early stage and prevent additional transmission. For example, the Joint United Nations Programme on HIV/AIDS (UNAIDS), a governmental organization based in Switzerland, reported in July 2024 that around 1.3 million people were newly infected with HIV in 2023, which is almost triple the 2025 target of below 370,000 cases. Therefore, the growing prevalence of HIV is set to enhance the expansion of the sexually transmitted diseases (STD) testing market.

How Is The Global Sexually Transmitted Diseases (STD) Testing Market Structured In Terms Of Segments?

The sexually transmitted diseases (STD) testing market covered in this report is segmented –

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Immunoassay, Molecular Diagnostics

3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types

4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV)

5) By End User: Individuals, Healthcare Providers, Health Insurance Providers, Govement Health Agencies, NGOs And Community Health Organizations

Subsegments:

1) By Instruments And Services: Diagnostic Instruments, Testing Services

2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes, And Other Lab Supplies

3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software

What Trends Are Currently Influencing Growth In The Sexually Transmitted Diseases (STD) Testing Market?

Leading firms in the STD-testing industry, such as iHealth Labs Inc., are innovating and developing advanced tools like syphilis testing kits to broaden the scope of STD testing. Syphilis testing kits act as diagnostic instruments that detect Treponema pallidum bacteria, responsible for syphilis, through body fluid or blood samples, ensuring timely diagnoses and treatments. For instance, in August 2023, the US-based medical device firm, iHealth Labs Inc., introduced the CheckMeSafe home use kit for HIV and syphilis testing. Suitable for those 18 years and older, the FDA-approved iHealth CheckMeSafe Home Collection kit enables users to gather blood samples for HIV (I, II, P24 antigen) and syphilis tests, conveniently from their homes. After collection, users can dispatch their samples to the laboratory using a prepaid overnight label and expect confidential and trustworthy outcome within two days. The kit guarantees remarkable accuracy, with 99.9% sensitivity for HIV and 99.5% for syphilis results. A CLIA-certified and CAP-credited laboratory analyzes all samples, assuring federal and state quality standards are maintained via regular inspections.

Who Are The Main Participants Shaping The Sexually Transmitted Diseases (STD) Testing Market Landscape?

Major companies operating in the sexually transmitted diseases (STD) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-diseases-std-testing-global-market-report

Which Region Currently Holds The Largest Share In The Sexually Transmitted Diseases (STD) Testing Market?

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted diseases (STD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24695&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model